PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
UPC vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between UPC and SPY is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

UPC vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Universe Pharmaceuticals INC (UPC) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%SeptemberOctoberNovemberDecember2025February
-99.74%
62.78%
UPC
SPY

Key characteristics

Sharpe Ratio

UPC:

-0.35

SPY:

1.82

Sortino Ratio

UPC:

-1.16

SPY:

2.45

Omega Ratio

UPC:

0.84

SPY:

1.33

Calmar Ratio

UPC:

-0.99

SPY:

2.76

Martin Ratio

UPC:

-1.58

SPY:

11.44

Ulcer Index

UPC:

62.64%

SPY:

2.03%

Daily Std Dev

UPC:

287.31%

SPY:

12.74%

Max Drawdown

UPC:

-99.81%

SPY:

-55.19%

Current Drawdown

UPC:

-99.78%

SPY:

-1.47%

Returns By Period

In the year-to-date period, UPC achieves a -69.84% return, which is significantly lower than SPY's 2.51% return.


UPC

YTD

-69.84%

1M

-70.23%

6M

-99.68%

1Y

-99.04%

5Y*

N/A

10Y*

N/A

SPY

YTD

2.51%

1M

1.91%

6M

13.44%

1Y

22.11%

5Y*

14.33%

10Y*

13.24%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

UPC vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UPC
The Risk-Adjusted Performance Rank of UPC is 1010
Overall Rank
The Sharpe Ratio Rank of UPC is 2828
Sharpe Ratio Rank
The Sortino Ratio Rank of UPC is 88
Sortino Ratio Rank
The Omega Ratio Rank of UPC is 88
Omega Ratio Rank
The Calmar Ratio Rank of UPC is 00
Calmar Ratio Rank
The Martin Ratio Rank of UPC is 44
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 7676
Overall Rank
The Sharpe Ratio Rank of SPY is 7575
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 7373
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 7575
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 7878
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 8080
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

UPC vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Universe Pharmaceuticals INC (UPC) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for UPC, currently valued at -0.35, compared to the broader market-2.000.002.004.00-0.351.82
The chart of Sortino ratio for UPC, currently valued at -1.16, compared to the broader market-4.00-2.000.002.004.00-1.162.45
The chart of Omega ratio for UPC, currently valued at 0.84, compared to the broader market0.501.001.502.000.841.33
The chart of Calmar ratio for UPC, currently valued at -0.99, compared to the broader market0.002.004.006.00-0.992.76
The chart of Martin ratio for UPC, currently valued at -1.58, compared to the broader market-30.00-20.00-10.000.0010.0020.0030.00-1.5811.44
UPC
SPY

The current UPC Sharpe Ratio is -0.35, which is lower than the SPY Sharpe Ratio of 1.82. The chart below compares the historical Sharpe Ratios of UPC and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
-0.35
1.82
UPC
SPY

Dividends

UPC vs. SPY - Dividend Comparison

UPC has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.18%.


TTM20242023202220212020201920182017201620152014
UPC
Universe Pharmaceuticals INC
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.18%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

UPC vs. SPY - Drawdown Comparison

The maximum UPC drawdown since its inception was -99.81%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for UPC and SPY. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-99.78%
-1.47%
UPC
SPY

Volatility

UPC vs. SPY - Volatility Comparison

Universe Pharmaceuticals INC (UPC) has a higher volatility of 60.44% compared to SPDR S&P 500 ETF (SPY) at 3.78%. This indicates that UPC's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%50.00%100.00%150.00%SeptemberOctoberNovemberDecember2025February
60.44%
3.78%
UPC
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab